{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T04:01:58Z","timestamp":1793505718432,"version":"4.5.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Indian Heart Journal"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.ihj.2022.10.195","type":"journal-article","created":{"date-parts":[[2022,11,2]],"date-time":"2022-11-02T12:40:05Z","timestamp":1667392805000},"page":"494-499","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Comparison of diltiazem and metoprolol for atrial fibrillation with rapid ventricular rate: Systematic review and meta-analysis"],"prefix":"10.1016","volume":"74","author":[{"given":"Saurabh C.","family":"Sharda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6286-1231","authenticated-orcid":false,"given":"Mandip S.","family":"Bhatia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ihj.2022.10.195_bib1","first-page":"38","article-title":"Canadian Cardiovascular Society atrial fibrillation guidelines 2010: management of recent-onset atrial fibrillation and flutter in the emergency department","volume":"27","author":"Stiell","year":"2011","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.ihj.2022.10.195_bib2","series-title":"Revised Cochrane Risk-Of-Bias Tool for Randomized Trials (RoB 2)","author":"Higgins","year":"2019"},{"issue":"1","key":"10.1016\/j.ihj.2022.10.195_bib4","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1097\/01.ccm.0000619468.31684.c1","article-title":"Evaluation of metoprolol versus diltiazem for treatment of atrial fibrillation in critical care unit","volume":"48","author":"Lopez","year":"2020","journal-title":"Crit Care Med"},{"issue":"13_suppl ment","key":"10.1016\/j.ihj.2022.10.195_bib5","article-title":"Intravenous diltiazem, as compared to intravenous metoprolol, for atrial fibrillation\/flutter is associated with increased admission from the emergency department","volume":"67","author":"Wei","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.ihj.2022.10.195_bib6","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1097\/SHK.0000000000000869","article-title":"Management of atrial fibrillation with rapid ventricular response in the intensive care unit: a secondary analysis of electronic health record data","volume":"48","author":"Moskowitz","year":"2017","journal-title":"Shock"},{"key":"10.1016\/j.ihj.2022.10.195_bib7","series-title":"Intravenous Diltiazem or Metoprolol Administration in the Emergency Department for Acute Rate Control of Atrial Fibrillation Patients with Rapid Ventricular Response with Unknown Ejection Fraction. D\u00fczce T\u0131p Fak\u00fcltesi Derg [Internet]","author":"DemiR","year":"2021"},{"issue":"6","key":"10.1016\/j.ihj.2022.10.195_bib8","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1136\/emj.2003.012047","article-title":"Comparison of the effectiveness of intravenous diltiazem and metoprolol in the management of rapid ventricular rate in atrial fibrillation","volume":"22","author":"Demircan","year":"2005","journal-title":"Emerg Med J"},{"issue":"1","key":"10.1016\/j.ihj.2022.10.195_bib9","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ajem.2017.09.013","article-title":"Achieving ventricular rate control in patients taking chronic beta-blocker therapy","volume":"36","author":"Feeney","year":"2018","journal-title":"Am J Emerg Med"},{"issue":"2","key":"10.1016\/j.ihj.2022.10.195_bib10","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.jemermed.2015.01.014","article-title":"Diltiazem vs. Metoprolol in the management of atrial fibrillation or flutter with rapid ventricular rate in the emergency department","volume":"49","author":"Fromm","year":"2015","journal-title":"J\u00a0Emerg Med"},{"key":"10.1016\/j.ihj.2022.10.195_bib11","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ajem.2020.11.073","article-title":"Comparison of sustained rate control in atrial fibrillation with rapid ventricular rate: metoprolol vs. Diltiazem","volume":"40","author":"Hargrove","year":"2021","journal-title":"Am J Emerg Med"},{"issue":"24","key":"10.1016\/j.ihj.2022.10.195_bib12","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.2146\/ajhp160126","article-title":"Diltiazem versus metoprolol for rate control in atrial fibrillation with rapid ventricular response in the emergency department","volume":"73","author":"Hines","year":"2016","journal-title":"Am J Health Syst Pharm"},{"issue":"1","key":"10.1016\/j.ihj.2022.10.195_bib13","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.ajem.2018.04.062","article-title":"Metoprolol vs. diltiazem in the acute management of atrial fibrillation in patients with heart failure with reduced ejection fraction","volume":"37","author":"Hirschy","year":"2019","journal-title":"Am J Emerg Med"},{"issue":"8","key":"10.1016\/j.ihj.2022.10.195_bib14","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1016\/j.cardfail.2014.06.117","article-title":"Treating rapid atrial fibrillation in acute decompensated heart failure: metoprolol and diltiazem are equally safe, yet metoprolol increases conversion to sinus rhythm","volume":"20","author":"Katchi","year":"2014","journal-title":"J\u00a0Card Fail"},{"key":"10.1016\/j.ihj.2022.10.195_bib15","article-title":"Evaluation of metoprolol versus diltiazem for rate control of atrial fibrillation in the emergency department","author":"McGrath","year":"2020","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.ihj.2022.10.195_bib16","doi-asserted-by":"crossref","DOI":"10.1177\/20503121211017756","article-title":"Rate control with intravenous diltiazem, verapamil, and metoprolol in acute atrial fibrillation with rapid ventricular rate","volume":"vol. 9","author":"Medeiros","year":"2021","journal-title":"SAGE Open Med"},{"key":"10.1016\/j.ihj.2022.10.195_bib17","article-title":"Which one is the first choice for rapid ventricular rate atrial fibrillation in emergency department: metoprolol or Diltiazem? A randomized clinical trial","author":"Memi\u015f","year":"2018","journal-title":"J\u00a0Surg Med"},{"issue":"9","key":"10.1016\/j.ihj.2022.10.195_bib18","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1016\/j.ajem.2020.06.034","article-title":"Hemodynamic comparison of intravenous push diltiazem versus metoprolol for atrial fibrillation rate control","volume":"38","author":"Nicholson","year":"2020","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.ihj.2022.10.195_bib19","article-title":"Evaluation of the blood pressure effects of diltiazem versus metoprolol in the acute treatment of atrial fibrillation with rapid ventricular rate","author":"Nu\u00f1ez Cruz","year":"2020","journal-title":"Am J Emerg Med"},{"issue":"3","key":"10.1016\/j.ihj.2022.10.195_bib20","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1177\/1060028013512473","article-title":"Intravenous metoprolol versus diltiazem for rate control in noncardiac, nonthoracic postoperative atrial fibrillation","volume":"48","author":"Personett","year":"2014","journal-title":"Ann Pharmacother"},{"issue":"6","key":"10.1016\/j.ihj.2022.10.195_bib21","doi-asserted-by":"crossref","first-page":"C82","DOI":"10.12968\/hmed.2019.80.6.C82","article-title":"Acute management of atrial fibrillation with rapid ventricular response","volume":"80","author":"Low","year":"2019","journal-title":"Br J Hosp Med Lond Engl"},{"issue":"23","key":"10.1016\/j.ihj.2022.10.195_bib22","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1161\/CIR.0000000000000040","article-title":"2014 AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology\/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society","volume":"130","author":"January","year":"2014","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.ihj.2022.10.195_bib23","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.bja.2019.08.015","article-title":"Use of the GRADE approach in systematic reviews and guidelines","volume":"123","author":"Granholm","year":"2019","journal-title":"Br J Anaesth"},{"issue":"4","key":"10.1016\/j.ihj.2022.10.195_bib24","first-page":"509","article-title":"Rate control management of atrial fibrillation with rapid ventricular response in the emergency department","volume":"36","author":"Wong","year":"2020","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.ihj.2022.10.195_bib25","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.ajem.2021.06.053","article-title":"Diltiazem versus metoprolol for the management of atrial fibrillation: a systematic review and meta-analysis","volume":"48","author":"Jafri","year":"2021","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.ihj.2022.10.195_bib26","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.ajem.2021.08.082","article-title":"Intravenous diltiazem versus metoprolol for atrial fibrillation with rapid ventricular rate: a meta-analysis","volume":"51","author":"Lan","year":"2022","journal-title":"Am J Emerg Med"}],"container-title":["Indian Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001948322200356X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001948322200356X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T03:56:27Z","timestamp":1758081387000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S001948322200356X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":25,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["S001948322200356X"],"URL":"https:\/\/doi.org\/10.1016\/j.ihj.2022.10.195","relation":{},"ISSN":["0019-4832"],"issn-type":[{"value":"0019-4832","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of diltiazem and metoprolol for atrial fibrillation with rapid ventricular rate: Systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Indian Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ihj.2022.10.195","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Cardiological Society of India. Published by Elsevier, a division of RELX India, Pvt. Ltd.","name":"copyright","label":"Copyright"}]}}